# Espey MFG & Electronics Corp: financial statements, quarterly

ESP · NYSE · CIK 33533 · [Technology](/sectors/technology.md) · fiscal year ends Jun 30

Pages: [Overview](/companies/esp.md) · [Financials](/companies/esp/financials.md) · [Filings](/companies/esp/filings.md) · [Insiders](/companies/esp/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/esp/financials.md?period=annual).

## Income statement

| Line item | Unit | Q1 FY2024 (2023-09-30) | Q2 FY2024 (2023-12-31) | Q3 FY2024 (2024-03-31) | Q4 FY2024 (2024-06-30) | Q1 FY2025 (2024-09-30) | Q2 FY2025 (2024-12-31) | Q3 FY2025 (2025-03-31) | Q4 FY2025 (2025-06-30) | Q1 FY2026 (2025-09-30) | Q2 FY2026 (2025-12-31) | Q3 FY2026 (2026-03-31) | Q4 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | [8.6](/filings/0001174947-25-001227.md) | [10.3](/filings/0001174947-25-001227.md) | [8.3](/filings/0001174947-25-001227.md) | [11.6](/filings/0001174947-25-001227.md) | [10.4](/filings/0001174947-26-000891.md) | [13.6](/filings/0001174947-26-000891.md) | [10.3](/filings/0001174947-26-000891.md) | [9.6](/filings/0001174947-26-000891.md) | [9.1](/filings/0001174947-26-000891.md) | [12.1](/filings/0001174947-26-000891.md) | [11.4](/filings/0001174947-26-000891.md) | [13.5](/filings/0001174947-26-000891.md) |
| Cost of revenue | $m | [6.3](/filings/0001174947-24-001258.md) | [7.2](/filings/0001174947-25-000162.md) | [6.2](/filings/0001174947-25-000741.md) | [8.4 d](/filings/0001174947-25-001227.md) | [7.6](/filings/0001174947-25-001381.md) | [10.4](/filings/0001174947-26-000152.md) | [7.4](/filings/0001174947-26-000585.md) | [5.8 d](/filings/0001174947-26-000891.md) | [5.9](/filings/0001174947-25-001381.md) | [7.9](/filings/0001174947-26-000152.md) | [7.2](/filings/0001174947-26-000585.md) | [8.8 d](/filings/0001174947-26-000891.md) |
| Gross profit | $m | [2.2](/filings/0001174947-25-001227.md) | [3.1](/filings/0001174947-25-001227.md) | [2.1](/filings/0001174947-25-001227.md) | [3.2](/filings/0001174947-25-001227.md) | [2.8](/filings/0001174947-26-000891.md) | [3.2](/filings/0001174947-26-000891.md) | [2.9](/filings/0001174947-26-000891.md) | [3.8](/filings/0001174947-26-000891.md) | [3.2](/filings/0001174947-26-000891.md) | [4.2](/filings/0001174947-26-000891.md) | [4.2](/filings/0001174947-26-000891.md) | [4.6](/filings/0001174947-26-000891.md) |
| Selling, general and administrative | $m | [1.0](/filings/0001174947-24-001258.md) | [1.0](/filings/0001174947-25-000162.md) | [1.0](/filings/0001174947-25-000741.md) | [1.1 d](/filings/0001174947-25-001227.md) | [1.1](/filings/0001174947-25-001381.md) | [1.1](/filings/0001174947-26-000152.md) | [1.2](/filings/0001174947-26-000585.md) | [1.1 d](/filings/0001174947-26-000891.md) | [1.2](/filings/0001174947-25-001381.md) | [1.1](/filings/0001174947-26-000152.md) | [1.2](/filings/0001174947-26-000585.md) | [1.2 d](/filings/0001174947-26-000891.md) |
| Operating income | $m | [1.2](/filings/0001174947-24-001258.md) | [2.1](/filings/0001174947-25-000162.md) | [1.1](/filings/0001174947-25-000741.md) | [2.1 d](/filings/0001174947-25-001227.md) | [1.7](/filings/0001174947-25-001381.md) | [2.0](/filings/0001174947-26-000152.md) | [1.8](/filings/0001174947-26-000585.md) | [2.6 d](/filings/0001174947-26-000891.md) | [2.1](/filings/0001174947-25-001381.md) | [3.1](/filings/0001174947-26-000152.md) | [3.0](/filings/0001174947-26-000585.md) | [3.5 d](/filings/0001174947-26-000891.md) |
| Income tax | $m | [0.3](/filings/0001174947-24-001258.md) | [0.5](/filings/0001174947-25-000162.md) | [0.2](/filings/0001174947-25-000741.md) | [0.5 d](/filings/0001174947-25-001227.md) | [0.4](/filings/0001174947-25-001381.md) | [0.4](/filings/0001174947-26-000152.md) | [0.4](/filings/0001174947-26-000585.md) | [0.4 d](/filings/0001174947-26-000891.md) | [0.4](/filings/0001174947-25-001381.md) | [0.7](/filings/0001174947-26-000152.md) | [0.5](/filings/0001174947-26-000585.md) | [0.5 d](/filings/0001174947-26-000891.md) |
| Net income | $m | [1.1](/filings/0001174947-25-001227.md) | [1.8](/filings/0001174947-25-001227.md) | [1.0](/filings/0001174947-25-001227.md) | [1.9](/filings/0001174947-25-001227.md) | [1.6](/filings/0001174947-26-000891.md) | [1.9](/filings/0001174947-26-000891.md) | [1.7](/filings/0001174947-26-000891.md) | [2.9](/filings/0001174947-26-000891.md) | [2.2](/filings/0001174947-26-000891.md) | [2.8](/filings/0001174947-26-000891.md) | [2.9](/filings/0001174947-26-000891.md) | [3.3](/filings/0001174947-26-000891.md) |
| Diluted EPS | $ per share | [0.44](/filings/0001174947-25-001227.md) | [0.72](/filings/0001174947-25-001227.md) | [0.40](/filings/0001174947-25-001227.md) | [0.73](/filings/0001174947-25-001227.md) | [0.61](/filings/0001174947-26-000891.md) | [0.71](/filings/0001174947-26-000891.md) | [0.63](/filings/0001174947-26-000891.md) | [1.05](/filings/0001174947-26-000891.md) | [0.76](/filings/0001174947-26-000891.md) | [0.99](/filings/0001174947-26-000891.md) | [0.99](/filings/0001174947-26-000891.md) | [1.15](/filings/0001174947-26-000891.md) |
| Basic EPS | $ per share | [0.44](/filings/0001174947-25-001227.md) | [0.73](/filings/0001174947-25-001227.md) | [0.41](/filings/0001174947-25-001227.md) | [0.76](/filings/0001174947-25-001227.md) | [0.63](/filings/0001174947-26-000891.md) | [0.74](/filings/0001174947-26-000891.md) | [0.66](/filings/0001174947-26-000891.md) | [1.10](/filings/0001174947-26-000891.md) | [0.80](/filings/0001174947-26-000891.md) | [1.02](/filings/0001174947-26-000891.md) | [1.03](/filings/0001174947-26-000891.md) | [1.18](/filings/0001174947-26-000891.md) |

- Revenue: us-gaap:Revenues
- Cost of revenue: us-gaap:CostOfRevenue
- Gross profit: us-gaap:GrossProfit
- Selling, general and administrative: us-gaap:SellingGeneralAndAdministrativeExpense
- Operating income: us-gaap:OperatingIncomeLoss
- Income tax: us-gaap:IncomeTaxExpenseBenefit
- Net income: us-gaap:NetIncomeLoss
- Diluted EPS: us-gaap:EarningsPerShareDiluted
- Basic EPS: us-gaap:EarningsPerShareBasic

## Balance sheet

| Line item | Unit | Q1 FY2024 (2023-09-30) | Q2 FY2024 (2023-12-31) | Q3 FY2024 (2024-03-31) | FY2024 (2024-06-30) | Q1 FY2025 (2024-09-30) | Q2 FY2025 (2024-12-31) | Q3 FY2025 (2025-03-31) | FY2025 (2025-06-30) | Q1 FY2026 (2025-09-30) | Q2 FY2026 (2025-12-31) | Q3 FY2026 (2026-03-31) | FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $m | [3.1](/filings/0001174947-23-001391.md) | [3.6](/filings/0001174947-24-000207.md) | [5.6](/filings/0001174947-24-000742.md) | [4.4](/filings/0001174947-25-001227.md) | [4.8](/filings/0001174947-24-001258.md) | [8.0](/filings/0001174947-25-000162.md) | [13.9](/filings/0001174947-25-000741.md) | [18.9](/filings/0001174947-26-000585.md) | [22.2](/filings/0001174947-25-001381.md) | [17.8](/filings/0001174947-26-000152.md) | [21.2](/filings/0001174947-26-000585.md) | not reported |
| Current assets | $m | [45.4](/filings/0001174947-23-001391.md) | [45.3](/filings/0001174947-24-000207.md) | [50.4](/filings/0001174947-24-000742.md) | [53.2](/filings/0001174947-25-001227.md) | [53.8](/filings/0001174947-24-001258.md) | [55.6](/filings/0001174947-25-000162.md) | [67.4](/filings/0001174947-25-000741.md) | [74.0](/filings/0001174947-26-000891.md) | [80.7](/filings/0001174947-25-001381.md) | [80.9](/filings/0001174947-26-000152.md) | [90.1](/filings/0001174947-26-000585.md) | [91.3](/filings/0001174947-26-000891.md) |
| Total assets | $m | [49.4](/filings/0001174947-23-001391.md) | [50.4](/filings/0001174947-24-000207.md) | [53.1](/filings/0001174947-24-000742.md) | [56.5](/filings/0001174947-25-001227.md) | [57.6](/filings/0001174947-24-001258.md) | [60.2](/filings/0001174947-25-000162.md) | [72.8](/filings/0001174947-25-000741.md) | [79.1](/filings/0001174947-26-000891.md) | [84.8](/filings/0001174947-25-001381.md) | [85.2](/filings/0001174947-26-000152.md) | [96.0](/filings/0001174947-26-000585.md) | [97.2](/filings/0001174947-26-000891.md) |
| Current liabilities | $m | [12.7](/filings/0001174947-23-001391.md) | [12.1](/filings/0001174947-24-000207.md) | [13.8](/filings/0001174947-24-000742.md) | [15.3](/filings/0001174947-25-001227.md) | [15.1](/filings/0001174947-24-001258.md) | [15.4](/filings/0001174947-25-000162.md) | [26.5](/filings/0001174947-25-000741.md) | [28.3](/filings/0001174947-26-000891.md) | [33.9](/filings/0001174947-25-001381.md) | [32.0](/filings/0001174947-26-000152.md) | [39.6](/filings/0001174947-26-000585.md) | [36.6](/filings/0001174947-26-000891.md) |
| Total liabilities | $m | [12.7](/filings/0001174947-23-001391.md) | [12.1](/filings/0001174947-24-000207.md) | [13.8](/filings/0001174947-24-000742.md) | [15.3](/filings/0001174947-25-001227.md) | [15.1](/filings/0001174947-24-001258.md) | [15.4](/filings/0001174947-25-000162.md) | [26.5](/filings/0001174947-25-000741.md) | [28.3](/filings/0001174947-26-000891.md) | [33.9](/filings/0001174947-25-001381.md) | [32.0](/filings/0001174947-26-000152.md) | [39.6](/filings/0001174947-26-000585.md) | [36.6](/filings/0001174947-26-000891.md) |
| Shareholders' equity | $m | [36.7](/filings/0001174947-25-000162.md) | [38.2](/filings/0001174947-25-000741.md) | [39.3](/filings/0001174947-25-000741.md) | [41.3](/filings/0001174947-26-000891.md) | [42.5](/filings/0001174947-26-000152.md) | [44.8](/filings/0001174947-26-000585.md) | [46.3](/filings/0001174947-26-000585.md) | [50.8](/filings/0001174947-26-000891.md) | [51.0](/filings/0001174947-26-000152.md) | [53.2](/filings/0001174947-26-000585.md) | [56.4](/filings/0001174947-26-000585.md) | [60.6](/filings/0001174947-26-000891.md) |

- Cash and equivalents: us-gaap:CashAndCashEquivalentsAtCarryingValue
- Current assets: us-gaap:AssetsCurrent
- Total assets: us-gaap:Assets
- Current liabilities: us-gaap:LiabilitiesCurrent
- Total liabilities: us-gaap:Liabilities
- Shareholders' equity: us-gaap:StockholdersEquity

## Cash flow

| Line item | Unit | Q1 FY2024 (2023-09-30) | Q2 FY2024 (2023-12-31) | Q3 FY2024 (2024-03-31) | Q4 FY2024 (2024-06-30) | Q1 FY2025 (2024-09-30) | Q2 FY2025 (2024-12-31) | Q3 FY2025 (2025-03-31) | Q4 FY2025 (2025-06-30) | Q1 FY2026 (2025-09-30) | Q2 FY2026 (2025-12-31) | Q3 FY2026 (2026-03-31) | Q4 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Operating cash flow | $m | [2.6](/filings/0001174947-24-001258.md) | [3.3 d](/filings/0001174947-25-000162.md) | [1.4 d](/filings/0001174947-25-000741.md) | [3.2 d](/filings/0001174947-25-001227.md) | [1.4](/filings/0001174947-25-001381.md) | [5.4 d](/filings/0001174947-26-000152.md) | [11.5 d](/filings/0001174947-26-000585.md) | [2.8 d](/filings/0001174947-26-000891.md) | [5.7](/filings/0001174947-25-001381.md) | [(2.8) d](/filings/0001174947-26-000152.md) | [3.4 d](/filings/0001174947-26-000585.md) | [(0.6) d](/filings/0001174947-26-000891.md) |
| Capital expenditure | $m | [2.2](/filings/0001174947-24-001258.md) | [1.2 d](/filings/0001174947-25-000162.md) | [1.0 d](/filings/0001174947-25-000741.md) | [0.7 d](/filings/0001174947-25-001227.md) | [0.7](/filings/0001174947-25-001381.md) | [0.9 d](/filings/0001174947-26-000152.md) | [1.0 d](/filings/0001174947-26-000585.md) | [1.9 d](/filings/0001174947-26-000891.md) | [1.3](/filings/0001174947-25-001381.md) | [1.3 d](/filings/0001174947-26-000152.md) | [0.2 d](/filings/0001174947-26-000585.md) | [0.3 d](/filings/0001174947-26-000891.md) |
| Dividends paid | $m | not reported | not reported | [0.4 d](/filings/0001174947-25-000741.md) | [0.5 d](/filings/0001174947-25-001227.md) | [0.6](/filings/0001174947-25-001381.md) | [0.6 d](/filings/0001174947-26-000152.md) | [0.6 d](/filings/0001174947-26-000585.md) | [0.7 d](/filings/0001174947-26-000891.md) | [2.7](/filings/0001174947-25-001381.md) | [0.7 d](/filings/0001174947-26-000152.md) | [0.7 d](/filings/0001174947-26-000585.md) | [0.7 d](/filings/0001174947-26-000891.md) |
| Share repurchases | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |

- Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities
- Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
- Dividends paid: us-gaap:PaymentsOfDividendsCommonStock
- Share repurchases: not reported

## Shares

| Line item | Unit | Q1 FY2023 (2022-09-30) | Q2 FY2023 (2022-12-31) | Q3 FY2023 (2023-03-31) | Q1 FY2024 (2023-09-30) | Q2 FY2024 (2023-12-31) | Q3 FY2024 (2024-03-31) | Q1 FY2025 (2024-09-30) | Q2 FY2025 (2024-12-31) | Q3 FY2025 (2025-03-31) | Q1 FY2026 (2025-09-30) | Q2 FY2026 (2025-12-31) | Q3 FY2026 (2026-03-31) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Diluted shares (weighted) | thousands of shares | [2,448](/filings/0001174947-23-001391.md) | [2,452](/filings/0001174947-24-000207.md) | [2,484](/filings/0001174947-24-000742.md) | [2,486](/filings/0001174947-24-001258.md) | [2,499](/filings/0001174947-25-000162.md) | [2,572](/filings/0001174947-25-000741.md) | [2,600](/filings/0001174947-25-001381.md) | [2,708](/filings/0001174947-26-000152.md) | [2,700](/filings/0001174947-26-000585.md) | [2,845](/filings/0001174947-25-001381.md) | [2,846](/filings/0001174947-26-000152.md) | [2,886](/filings/0001174947-26-000585.md) |

- Diluted shares (weighted): us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding

Shares outstanding: 3,036,872 at 2026-09-15, from the cover of the [10-K filed 2026-09-23](/filings/0001174947-26-000891.md) (dei:EntityCommonStockSharesOutstanding).

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:18 ET. No prices; not investment advice.